US Stock MarketDetailed Quotes
GLSI Greenwich LifeSciences
- 12.870
- +0.300+2.39%
Close Jan 17 16:00 ET
- 13.244
- +0.374+2.90%
Post 20:01 ET
169.17MMarket Cap-15.89P/E (TTM)
13.100High12.630Low34.81KVolume12.710Open12.570Pre Close447.17KTurnover0.59%Turnover RatioLossP/E (Static)13.14MShares21.44052wk High33.96P/B76.02MFloat Cap8.00052wk Low--Dividend TTM5.91MShs Float158.070Historical High--Div YieldTTM3.74%Amplitude3.262Historical Low12.844Avg Price1Lot Size
About Greenwich LifeSciences Company
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Company Profile
SymbolGLSI
Company NameGreenwich LifeSciences
Listing DateSep 25, 2020
Issue Price5.75
Founded2006
CEOMr. Snehal S. Patel
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address3992 Bluebonnet Drive,Building 14
CityStafford
ProvinceTexas
CountryUnited States of America
Zip Code77477
Phone1-832-819-3232
Company Executives
- Name
- Position
- Salary
- Snehal S. Patel
- Principal Accounting Officer, Chief Executive Officer, Chief Financial Officer and Director
- 2.75M
- Dr. F Joseph. Daugherty
- Chief Medical Officer and Director
- --
- Dr. Jaye Thompson, M.S.,PhD
- Vice President, Clinical and Regulatory Affairs
- --
- David B. McWilliams
- Chairman of the Board
- 98.39K
- Kenneth Hallock
- Independent Director
- 65.64K
- Eric Rothe
- Independent Director
- 65.64K
Heat List
US
Overall
Symbol
Price
% Chg
No Data